Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-23T13:56:58.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2; the study page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-16T14:16:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-09T13:52:37.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page instead of the study content, indicating an access/permission issue; as a result, users cannot view the study details on this page.
    Difference
    18%
    Check dated 2026-09-25T16:30:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, indicating a minor, behind-the-scenes update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-09-18T17:59:02.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study documents on the page were updated to Revision: v3.6.6, replacing the previous v3.6.5, indicating an updated protocol/document set for the study.
    Difference
    0.0%
    Check dated 2026-08-28T17:49:05.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.